Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.

Our mission is to facilitate the efficient development of optimal medicinal products, ranging from conventional to complex formulations, by leveraging scientific excellence. We are experts in all facets of dose selection and justification, including Drug Metabolism and Pharmacokinetics (DMPK), Clinical Pharmacology, Pharmaceutical Development, IND-NDA technical authoring, and GMP manufacturing. Our comprehensive suite of services encompasses consultancy, laboratory analysis, pharmacokinetic modelling and GMP manufacturing. This expertise enables us to guide clients through the entire drug development process, from initial discovery and preclinical studies to clinical trials and regulatory approval. Our focus is on designing and developing products that exhibit superior in vivo performance, robust manufacturability, and strong commercial potential. Based in Greater Manchester, UK, our cutting-edge facilities are equipped to support the rapid design, development, evaluation, and production of innovative formulations. By enhancing the value proposition of our global clients, we contribute to the advancement of new therapies, ultimately benefiting patients worldwide Expertise: Oral Drug Delivery DMPK Consultancy and Dose Selection Pharmacokinetic Modelling Complex Medicines Paediatric Product Development CMC Regulatory Clinical Pharmacology.
Separate GMP and development facilities wity matching analytical and manufacturing equipment. The development facility contains capabilitiess for oral solid dosage forms including amorphous solid dispertions alongside conventional tablets and capsules. Oral and parenteral liquid dosage forms are also developed in this facility in addition to more complex delivery approaches such as long acting injectables and nanoparticulate systems.
The GMP facility contains 5 high potent processing rooms equipped for the manufacture of non-sterile dosage forms including ASDs, lipidic systems, tablets, capsules and powders. Packing and labelling activities can also be undertaken followed by product certification and QP release.